Clinical Trial Update: First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of tersolisib (STX-478) as monotherapy and in combination with other anticancer agents in adults with advanced solid tumors, including br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tersolisib (tersolisib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Solid Tumors, Adult | Phase 1, Phase 2 | Status: RECRUITING